Welcome to World Journal of Gastrointestinal Pharmacology and Therapeutics

 

The World Journal of Gastrointestinal Pharmacology and Therapeutics (WJGPT) is a leading academic journal devoted to reporting the latest, cutting-edge research progress and findings of basic research and clinical practice in the field of gastrointestinal pharmacology and therapeutics.  It was launched on February 6, 2010 and is published trimonthly (4 issues annually) by BPG, the world's leading professional clinical medical journal publishing company.

 

We encourage pharmacology and therapeutics specialists worldwide to submit manuscripts to the WJGPT describing their original basic or clinical research findings that are of high academic value and which report new diagnostic techniques or summarize their treatment experiences.

 

The usual times related to all publication processes of the WJGPT are as follows: from manuscript receipt to peer review: 2-4 weeks; from initial manuscript acceptance, with revisions, to return of the revised manuscript from the authors: 4-5 weeks; from return of the revised manuscript from the authors to final acceptance: 1-2 weeks; from final acceptance to an article in press: 2 days; from article in press designation to formal release of the electronic version and all online documentation: 2-9 weeks. The WJGPT’s acceptance rate: 49%.  Submit here >>

Published Issues
1
Editors-in-Chief

Hugh Freeman, FRCP(C), MD, MSc, Professor

Indexing/Abstracting

PubMed, PubMed Central.

Impact Factor

There is currently no impact factor.

ISSN

2150-5349 (online)

Previous  |   Next  |   Latest  |   Archive
Contents Volume 7  Issue 1  February 6, 2016
Editorial
Proton pump inhibitor prescription abuse and sepsis in cirrhosis  
Antonio Picardi, Umberto Vespasiani-Gentilucci
World J Gastrointest Pharmacol Ther 7(1):1-4. Published online Feb 6, 2016. doi: 10.4292/wjgpt.v7.i1.1
Topic Highlight
Pharmacological- and non-pharmacological therapeutic approaches in inflammatory bowel disease in adults  
Gerda C Leitner, Harald Vogelsang
World J Gastrointest Pharmacol Ther 7(1):5-20. Published online Feb 6, 2016. doi: 10.4292/wjgpt.v7.i1.5
Review
Recent discoveries and emerging therapeutics in eosinophilic esophagitis  
Aakash Goyal, Edaire Cheng
World J Gastrointest Pharmacol Ther 7(1):21-32. Published online Feb 6, 2016. doi: 10.4292/wjgpt.v7.i1.21
Hepatitis C virus: A time for decisions. Who should be treated and when?  
Bashar M Attar, David H Van Thiel
World J Gastrointest Pharmacol Ther 7(1):33-40. Published online Feb 6, 2016. doi: 10.4292/wjgpt.v7.i1.33
Emerging role of novel biomarkers in the diagnosis of inflammatory bowel disease  
Anet A Soubières, Andrew Poullis
World J Gastrointest Pharmacol Ther 7(1):41-50. Published online Feb 6, 2016. doi: 10.4292/wjgpt.v7.i1.41
Elderly patients and inflammatory bowel disease  
Danielle Nimmons, Jimmy K Limdi
World J Gastrointest Pharmacol Ther 7(1):51-65. Published online Feb 6, 2016. doi: 10.4292/wjgpt.v7.i1.51
Eosinophilic esophagitis: New insights in pathogenesis and therapy  
Michele Pier Luca Guarino, Michele Cicala, Jose Behar
World J Gastrointest Pharmacol Ther 7(1):66-77. Published online Feb 6, 2016. doi: 10.4292/wjgpt.v7.i1.66
Diagnosis and management of functional symptoms in inflammatory bowel disease in remission  
Carlos Teruel, Elena Garrido, Francisco Mesonero
World J Gastrointest Pharmacol Ther 7(1):78-90. Published online Feb 6, 2016. doi: 10.4292/wjgpt.v7.i1.78
Clinical applications, limitations and future role of transient elastography in the management of liver disease  
Pik Eu Chang, George Boon-Bee Goh, Jing Hieng Ngu, Hiang Keat Tan, Chee Kiat Tan
World J Gastrointest Pharmacol Ther 7(1):91-106. Published online Feb 6, 2016. doi: 10.4292/wjgpt.v7.i1.91
Minireviews
Review of vedolizumab for the treatment of ulcerative colitis  
Michelle SY Lau, Her Hsin Tsai
World J Gastrointest Pharmacol Ther 7(1):107-111. Published online Feb 6, 2016. doi: 10.4292/wjgpt.v7.i1.107
Influence of environmental factors in the development of inflammatory bowel diseases  
Evangelia Legaki, Maria Gazouli
World J Gastrointest Pharmacol Ther 7(1):112-125. Published online Feb 6, 2016. doi: 10.4292/wjgpt.v7.i1.112
Helicobacter pylori and its reservoirs: A correlation with the gastric infection  
Spencer Luiz Marques Payão, Lucas Trevizani Rasmussen
World J Gastrointest Pharmacol Ther 7(1):126-132. Published online Feb 6, 2016. doi: 10.4292/wjgpt.v7.i1.126
Dendritic cell-based vaccine for pancreatic cancer in Japan  
Masato Okamoto, Masanori Kobayashi, Yoshikazu Yonemitsu, Shigeo Koido, Sadamu Homma
World J Gastrointest Pharmacol Ther 7(1):133-138. Published online Feb 6, 2016. doi: 10.4292/wjgpt.v7.i1.133
Retrospective Study
Under-diagnosing and under-treating iron deficiency in hospitalized patients with gastrointestinal bleeding  
Mustapha M El-Halabi, Michael S Green, Christopher Jones, William J Salyers Jr
World J Gastrointest Pharmacol Ther 7(1):139-144. Published online Feb 6, 2016. doi: 10.4292/wjgpt.v7.i1.139
Prospective Study
Effect of electrical stimulation of the lower esophageal sphincter in gastroesophageal reflux disease patients refractory to proton pump inhibitors  
Edy Soffer, Leonardo Rodríguez, Patricia Rodriguez, Beatriz Gómez, Manoel G Neto, Michael D Crowell
World J Gastrointest Pharmacol Ther 7(1):145-155. Published online Feb 6, 2016. doi: 10.4292/wjgpt.v7.i1.145
Randomized Controlled Trial
Therapeutic effect of melatonin on pediatric functional dyspepsia: A pilot study  
Katherine Zybach, Craig A Friesen, Jennifer V Schurman
World J Gastrointest Pharmacol Ther 7(1):156-161. Published online Feb 6, 2016. doi: 10.4292/wjgpt.v7.i1.156
Systematic Reviews
Economic evaluations in gastroenterology in Brazil: A systematic review  
Luciana Bertocco de Paiva Haddad, Tassia Cristina Decimoni, Jose Antonio Turri, Roseli Leandro, Patrícia Coelho de Soárez
World J Gastrointest Pharmacol Ther 7(1):162-170. Published online Feb 6, 2016. doi: 10.4292/wjgpt.v7.i1.162